Cleared Traditional

K002030 - OMNI-TRAK 3150/3155A SERIES MONITOR WITH ANESTHETIC AGENT, MODEL 3155A SERIES

K002030 is an FDA 510(k) clearance for OMNI-TRAK 3150/3155A SERIES MONITOR WIT..., manufactured by Invivo Research, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 85-day FDA review.

K002030 · Invivo Research, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2000
Decision
85d
Days
Class 2
Risk

K002030 is an FDA 510(k) clearance for the OMNI-TRAK 3150/3155A SERIES MONITOR WITH ANESTHETIC AGENT, MODEL 3155A SERIES. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Invivo Research, Inc. (Orlando, US). The FDA issued a Cleared decision on September 26, 2000 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Invivo Research, Inc. devices

FDA 510(k) Submission Details - K002030

510(k) Number K002030 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2000
Decision Date September 26, 2000
Days to Decision 85 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 125d · This submission: 85d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 180
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K002030.
M2376A DEVICELINK SYSTEM, MODEL M2376A
K003622 · Agilent Technologies, Inc. · Dec 2000
M2376A DEVICELINK SYSTEM
K003107 · Agilent Technologies, Inc. · Oct 2000
M2376A DEVICELINK SYSTEM, MODEL M2376A
K002967 · Agilent Technologies, Inc. · Oct 2000
HP M2376A DEVICE LINK SYSTEM, MODEL M2376A
K002009 · Agilent Technologies, Inc. · Aug 2000
WELCH ALLYN INSTRUMENT INTERFACE MODULE
K001265 · Welch Allyn, Inc. · Jul 2000
MODIFICATION TO HP M2376A DEVICE LINK SYSTEM, MODEL M2376A
K001776 · Agilent Technologies, Inc. · Jun 2000